185243-69-0

GPTKB entity

Statements (24)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:alsoKnownAs gptkb:AB-CHMINACA
gptkbp:CASNumber gptkb:185243-69-0
gptkbp:chemicalClass synthetic cannabinoid
gptkbp:detects designer drugs
gptkbp:effect cannabinoid receptor agonist
gptkbp:hasInChIKey QZJXJXJZQZJXJZ-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C20H28N4O2
gptkbp:hasPotentialAdverseEffect psychosis
seizures
toxicity
gptkbp:hasSMILES CC(C)[C@@H](C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CC3CCCCC3
gptkbp:hasUNII 2Q8V8U7E3F
https://www.w3.org/2000/01/rdf-schema#label 185243-69-0
gptkbp:IUPACName gptkb:N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
gptkbp:legalStatus controlled substance in some countries
gptkbp:molecularWeight 356.46 g/mol
gptkbp:PubChem_CID 86272952
gptkbp:relatedTo indazole-based synthetic cannabinoids
gptkbp:routeOfAdministration smoking
oral
inhalation
gptkbp:bfsParent gptkb:Enbrel
gptkbp:bfsLayer 6